Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation Research. 1992;71:70-81

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shafiq, J.
Right arrow Articles by Kuriyama, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shafiq, J.
Right arrow Articles by Kuriyama, H.

Circulation Research, Vol 71, 70-81, Copyright © 1992 by American Heart Association

ARTICLES

Mechanisms of vasodilation induced by NKH477, a water-soluble forskolin derivative, in smooth muscle of the porcine coronary artery

J Shafiq, S Suzuki, T Itoh and H Kuriyama
Department of Pharmacology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

To study the mechanism of vasodilation induced by 6-(3- dimethylaminopropionyl) forskolin (NKH477), a water-soluble forskolin derivative, its effects on the acetylcholine (ACh)-induced contraction of muscle strips of porcine coronary artery were examined. [Ca2+]i, isometric force, and cellular concentrations of cAMP and inositol 1,4,5- trisphosphate were measured. NKH477 (0.1-1.0 microM), isoproterenol (0.01-0.1 microM), or forskolin (0.1-1.0 microM) increased cAMP and attenuated the contraction induced by 128 mM K+ or 10 microM ACh in a concentration-dependent manner. These agents, at concentrations up to 0.3 microM, did not change the amount of cGMP. NKH477 (0.1 microM) attenuated the contraction induced by 128 mM K+ without corresponding changes in the evoked [Ca2+]i responses. ACh (10 microM) produced a large phasic increase followed by a small tonic increase in [Ca2+]i and produced a sustained contraction. The ACh-induced phasic increase in [Ca2+]i, but not the tonic increase, disappeared after application of 0.1 microM ionomycin. NKH477 (0.1 microM) attenuated both the increase in [Ca2+]i and the force induced by 10 microM ACh in muscle strips that were not treated with ionomycin and inhibited the ACh-induced contraction without corresponding changes in [Ca2+]i in ionomycin- treated muscle strips. These results suggest that NKH477 inhibits ACh- induced Ca2+ mobilization through its action on ionomycin-sensitive storage sites. In ionomycin-treated and 128 mM K(+)-treated muscle strips, 0.1 microM NKH477 shifted the [Ca2+]i-force relation to the right in the presence or absence of 10 microM ACh. In beta-escin- skinned smooth muscle strips, 0.1 microM NKH477 shifted the pCa-force relation to the right but had no effects on Ca(2+)-independent contraction. We conclude that in smooth muscle of porcine coronary artery, NKH477 inhibits ACh-induced contraction by both attenuating ACh- induced Ca2+ mobilization and reducing the sensitivity of the contractile machinery to Ca2+, possibly by activating cAMP-dependent mechanisms.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T. Matsumoto, K. Wakabayashi, T. Kobayashi, and K. Kamata
Functional changes in adenylyl cyclases and associated decreases in relaxation responses in mesenteric arteries from diabetic rats
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2234 - H2243.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T.-C. Mou, A. Gille, D. A. Fancy, R. Seifert, and S. R. Sprang
Structural Basis for the Inhibition of Mammalian Membrane Adenylyl Cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-Triphosphate
J. Biol. Chem., February 25, 2005; 280(8): 7253 - 7261.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Iwatsubo, S. Minamisawa, T. Tsunematsu, M. Nakagome, Y. Toya, J. E. Tomlinson, S. Umemura, R. M. Scarborough, D. E. Levy, and Y. Ishikawa
Direct Inhibition of Type 5 Adenylyl Cyclase Prevents Myocardial Apoptosis without Functional Deterioration
J. Biol. Chem., September 24, 2004; 279(39): 40938 - 40945.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Onda, Y. Hashimoto, M. Nagai, H. Kuramochi, S. Saito, H. Yamazaki, Y. Toya, I. Sakai, C. J. Homcy, K. Nishikawa, et al.
Type-specific Regulation of Adenylyl Cyclase. SELECTIVE PHARMACOLOGICAL STIMULATION AND INHIBITION OF ADENYLYL CYCLASE ISOFORMS
J. Biol. Chem., December 14, 2001; 276(51): 47785 - 47793.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. Ogata, K. Nakano, K. Sakamoto, and K. Minami
Preoperative Use of Colforsin Daropate Hydrochloride in a Patient with Severe Cardiac Function Scheduled for Y-Graft Replacement
Anesth. Analg., October 1, 2001; 93(4): 1079 - 1080.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. Hayashida, S. Chihara, E. Tayama, T. Takaseya, N. Enomoto, T. Kawara, and S. Aoyagi
Antiinflammatory effects of colforsin daropate hydrochloride, a novel water-soluble forskolin derivative
Ann. Thorac. Surg., June 1, 2001; 71(6): 1931 - 1938.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. H. Gao, N. C. Lai, D. M. Roth, J. Zhou, J. Zhu, T. Anzai, N. Dalton, and H. K. Hammond
Adenylylcyclase Increases Responsiveness to Catecholamine Stimulation in Transgenic Mice
Circulation, March 30, 1999; 99(12): 1618 - 1622.
[Abstract] [Full Text] [PDF]


Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.